Contact us 24/7
View all

Settlement Reached in Deadly Meningitis Outbreak Lawsuit

Destiny Baker3 years ago

According to CBS, insurers and owners of New England Compounding Pharmacy Inc. have agreed to pay $100 million to settle claims over tainted steroid injections.

About the Deadly Meningitis Outbreak

According to the U.S. Centers for Disease Control and Prevention (CDC), 751 people across 20 states have fallen ill due an outbreak of fungal meningitis linked to contaminated injections distributed by the Massachusetts-based compounding pharmacy.

Those affected suffered inflammation of the lining of the brain and spinal cord as well as other infections – 64 people have died.

More than 17,600 doses of the steroid, methylprednisolone actate, were shipped by the New England Compounding Center (NECC) to 23 states before the recall.

Upon investigation into the outbreaks, the U.S. Food and Drug Administration (FDA) were able to trace the strain of meningitis to the compounding center where they found vials containing a greenish black foreign matter and a white filamentous material which were later proved to be microbial growths.

The agency also confirmed that NECC had used non-sterile active ingredients to manufacturer the steroid injections.

Details of the Settlements

The proposed settlement would have investors and owners of the now-bankrupt compounding company pay more than $100 million in compensation to victims and victims’ families in connection to the deadly outbreak.

In the deal announced Monday, which is still awaiting a judge’s approval, the owners and insurers would admit no wrongdoing and the owners continue to deny liability for the outbreak.

The fatal outbreak has resulted in new legislation which gives the FDA regulatory authority over any compounding firm that distributes its products across state lines – a job originally left up to state officials.

Contact an Experienced Product Liability Attorney

Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.

If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.

HAVE YOU BEEN INJURED?

If you’ve been injured, we can help. Contact us